Furthermore, mutations in K-Ras occur most commonly in human cancers and developmental diseases, including pancreatic, colorectal, lung, cervical and hematological cancer, Noonan syndrome, and Cardio-facio-cutaneous syndrome [11]–[13]. This evidence concerns the gene KRAS and cancer.